Increasing Construction of Datacenters around the Globe to Foster the Growth of the Green UPS Market

 

Green UPS Market

UPS stands for Uninterrupted Power Supply and it is the most efficient way to provide uninterrupted power in various electronic appliances. It is a continuous electric supply that supplies power to any device or appliance that requires power, even in the absence of an electric power distributor or power line. An uninterruptible electric power supply is an electronic electrical device that supplies uninterrupted power to a backup load when the main electric power source or main mains power fails. A growing number of data centers around the globe coupled with the rising adoption of IoT is predominantly fueling the growth of the green UPS market. Moreover, the rising trend of cloud computing and virtualization has also boosted the growth of the green UPS market. The increasing launch of new data centers and the growing need for a secure & clean power supply for smooth operation is again driving the growth of the market. For instance, in August 2020, Legrand India announced the launch of Legrand Data Center Solutions (LDCS) which brings together a portfolio of global brands including Legrand, Numeric, Raritan & Server Technology under one specialist team. Legrand Data Center Solutions are modular, scalable, and customizable and are thus, designed for agility.

Europe is projected to gain significant growth over the forecast period and this is attributed to the continuous construction of data that run completely on renewable sources of energy in the region. For instance, in October 2020, European cloud hosting company UpCloud has opened a new data center in Madrid, Spain, in a bid to continue their international expansion. UpCloud’s new data center is located in Madrid, and it is the company’s first data center in Southern Europe. The new Interxion MAD3 facility uses 100% renewable energy, as certified by the Spanish National Market and Competition Commission (CNMC).

Key Developments:

1.     In July 2019, UPS announced the launch of new customer services and capabilities in the company’s recent history.  The new solutions are designed to capture growth opportunities in strategic markets: small- and medium-sized businesses (SMBs), e-commerce, high-growth international countries, and healthcare and life sciences

2.     In January 20201, Numeric, the UPS manufacturer and power quality solution provider in India announced the launch of the award-winning 3 Phase modular UPS, Keor MOD. The newly launched product is designed to meet the needs of the IT, ITeS, data center, infrastructure, and healthcare industry.

3.     In January 2020, AEG Power Solutions, a global provider of AC & DC power supply systems and solutions for critical and demanding applications, announced the launch of the new generation of Protect C and Protect D series of double-conversion online uninterruptible power supplies (UPS)

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more